Description

BPC-157 10MG

We provide BPC-157 as a 10MG synthetic pentadecapeptide research compound with a stated 99.1% purity. Furthermore, the peptide contains 15 amino acids arranged in the sequence GEPPPGKPADDAGLV. Consequently, researchers have investigated this compound across gastrointestinal biology, angiogenic signaling, nitric oxide pathways, vascular responses, and musculoskeletal tissue research.

Key Attributes

• Brand: AvigenLab
• Product Name: BPC-157
• Quantity: 10MG
• Stated Purity: 99.1%
• Molecular Type: Synthetic Pentadecapeptide
• Sequence: GEPPPGKPADDAGLV
• Sequence Length: 15 Amino Acids
• Molecular Formula: C₆₂H₉₈N₁₆O₂₂
• Molecular Weight: 1,419.5 g/mol
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

BPC-157 Product Overview

We provide BPC-157 for research involving peptide signaling, gastrointestinal biology, vascular responses, angiogenic pathways, and tissue-response mechanisms. Moreover, scientific literature describes the compound as a stable gastric pentadecapeptide that has attracted extensive preclinical research interest across multiple biological systems.

Additionally, researchers have examined relationships involving VEGFR2, nitric oxide signaling, FAK-paxillin activity, Egr-1 expression, and other cellular pathways. Therefore, the compound provides a broad experimental subject for studying interconnected mechanisms involved in vascular and tissue biology.

Explore additional research materials through our Online Store.

BPC-157 Product Identification

We identify BPC-157 as a 10MG research peptide carrying a stated 99.1% purity designation. Furthermore, PubChem records the sequence as GEPPPGKPADDAGLV, with a molecular formula of C₆₂H₉₈N₁₆O₂₂ and a molecular weight of 1,419.5 g/mol.

Accordingly, its molecular sequence, quantity, purity designation, vial format, and research classification provide clear reference points for laboratory documentation and inventory management.

Product Category

We classify BPC-157 within our research peptide collection, particularly within materials relevant to gastrointestinal, vascular, regenerative, and musculoskeletal research. Accordingly, its scientific profile extends across several interconnected areas of experimental biology.

Moreover, systematic research reviews have examined the compound across muscle, tendon, ligament, bone, and other tissue models. Consequently, researchers continue to investigate its relationship with growth-factor signaling, angiogenesis, inflammatory responses, and tissue biology.

Scientific Characteristics

BPC-157 contains 15 amino acids arranged as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. In particular, PubChem identifies the molecular formula as C₆₂H₉₈N₁₆O₂₂ and the molecular weight as 1,419.5 g/mol.

Furthermore, researchers have investigated several signaling pathways associated with the compound, including VEGFR2, FAK-paxillin, Egr-1, and nitric oxide-related mechanisms. Meanwhile, current research continues to examine how these pathways interact across different experimental models.

Research Applications

We position BPC-157 for research involving angiogenic signaling, gastrointestinal biology, vascular responses, nitric oxide pathways, connective-tissue biology, and musculoskeletal research.

Additionally, experimental studies have reported relationships between the peptide and VEGFR2 signaling, endothelial responses, angiogenic activity, and fibroblast-related processes. As a result, researchers have examined the compound extensively within experimental tissue and vascular models.

Likewise, researchers have investigated interactions with the nitric oxide system, including pathways involving endothelial nitric oxide synthase. Nevertheless, the available evidence remains predominantly preclinical, and findings can vary according to experimental model, preparation, route, and measured endpoint.

Product Configuration

We provide the material in a 10MG vial carrying a stated 99.1% purity designation. Accordingly, the defined quantity, peptide identity, molecular sequence, purity specification, and physical presentation create straightforward reference points for laboratory inventory and product documentation.

Furthermore, the vial configuration distinguishes this presentation from other product formats within our collection. Consequently, researchers can identify the material according to its molecular identity, quantity, purity, packaging, and research classification.

Product Features

The primary features include a 10MG quantity, 99.1% stated purity, synthetic pentadecapeptide structure, and clearly defined GEPPPGKPADDAGLV sequence. Additionally, our product label communicates Not For Human Use | Research Use Only.

Moreover, the scientific profile encompasses vascular signaling, gastrointestinal research, nitric oxide biology, and tissue-response mechanisms. Researchers have also examined FAK-paxillin and Egr-1-related pathways, while other investigations have explored VEGFR2-associated signaling.

Product Specifications

The molecular sequence, formula, and molecular weight correspond with the chemical identity documented by PubChem.

Intended Research Context

We identify the material as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine the peptide within experimental systems involving gastrointestinal signaling, vascular biology, angiogenesis, connective-tissue responses, and nitric oxide regulation. Furthermore, recent reviews continue to describe the evidence base as predominantly preclinical, with important questions remaining around pharmacokinetics, formulation, and clinical translation.

Nevertheless, experimental findings should not automatically translate into established human outcomes. Therefore, we maintain a clear distinction between documented research observations and clinical or therapeutic claims.

Packaging Information

We present the product in a clearly labeled 10MG vial featuring our AvigenLab product presentation. The packaging identifies the compound, displays the 10MG quantity, and communicates the stated 99.1% Purity designation.

Additionally, the label communicates Not For Human Use | Research Use Only. Therefore, the packaging provides straightforward product identification while supporting consistent laboratory inventory and catalog organization.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, scientific publications concerning BPC-157 do not constitute regulatory approval for this specific AvigenLab presentation.

Moreover, recent reviews continue to identify substantial translational barriers, including limited clinical evidence and the absence of an approved formulation or validated dosing regimen. Consequently, we focus our documentation on molecular identity, research applications, product specifications, and scientific literature rather than presenting experimental findings as established clinical outcomes.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because peptide stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our 10MG presentation provides a defined research peptide configuration within our product collection. The product name, quantity, stated purity, 15-amino-acid sequence, vial format, and Research Use Only classification create clear reference points for laboratory inventory.

Moreover, the compound maintains an extensive preclinical research history involving gastrointestinal, vascular, musculoskeletal, and tissue-response investigations. Likewise, continued research into VEGFR2, nitric oxide, FAK-paxillin, Egr-1, and related pathways keeps the material relevant to experimental biology.

Product Reference

Our BPC-157 10MG presentation provides a defined synthetic pentadecapeptide with a stated 99.1% purity designation. We document the material according to its GEPPPGKPADDAGLV sequence, molecular characteristics, vial configuration, research applications, and Research Use Only status.

Consequently, the product provides researchers with a clearly identified material for investigating angiogenic signaling, gastrointestinal biology, nitric oxide pathways, vascular responses, and musculoskeletal tissue mechanisms. Furthermore, ongoing research continues to examine the interconnected signaling pathways associated with the compound while researchers work to clarify its pharmacological and translational characteristics.